Long eyelashes in a case series of 93 children with vernal keratoconjunctivitis

Pediatrics

Volumn 115, Issue 1, 2005, Pages

  Pucci, Neri ^a   Novembre, Elio ^a   Lombardi, Enrico ^a   Massai, Cristina ^a   Bernardini, Roberto ^a   Caputo, Roberto ^a   Campa, Luciana ^a   De Libero, Cinzia ^a   Vierucci, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Children; Eyelashes; Vernal keratoconjunctivitis

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; CYCLOSPORIN; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; NONSTEROID ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BLOOD; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEFENSE MECHANISM; DISEASE SEVERITY; EOSINOPHIL COUNT; EVALUATION; EYELASH; FEMALE; GENDER; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INSTRUMENTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SKIN TEST; STATISTICAL SIGNIFICANCE; VERNAL CONJUNCTIVITIS; AGING; ALLERGIC CONJUNCTIVITIS; CASE CONTROL STUDY; DRUG EFFECT; HISTOLOGY; PATHOLOGY; PRESCHOOL CHILD; REFERENCE VALUE;

ADOLESCENT; AGING; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CONJUNCTIVITIS, ALLERGIC; CYCLOSPORINE; EYELASHES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MULTIVARIATE ANALYSIS; REFERENCE VALUES;

EID: 16844373447     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1555     Document Type: Article

References (45)

1. Calonge M. Classification of ocular atopic/allergic disorders and conditions: an unsolved problem. Acta Ophthalmol Scand. 1999;77:10-13
2. Collum MT. Vernal keratoconjunctivitis. Acta Ophthalmol Scand. 1999;77:14-16
3. Bleik JH, Tabbara KF. Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology. 1991;98:1679-1684
4. Bonini S, Bonini S, Lambiase A, et al. Vernal keratoconjunctivitis revisited. A case series of 195 patients with long-term followup. Ophthalmology. 2000;107:1157-1163
5. Maggi E, Biswas P, Del Prete G, Parronchi P, Macchia D, Simonelli C. Accumulation of Th2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol. 1991;146:1169-1174
6. Leonardi A, DeFranchis G, Zancanaro F, et al. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. Invest Ophthalmol Vis Sci. 1999;40:3036-3040
7. Hingorani M, Calder V, Jolly G, Buckley RJ, Lightman SL. Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol. 1998;102:821-830
8. Leonardi A, Jose PJ, Zhan H, Calder VL. Tear and mucus eotaxin-1 and eotaxin-2 in allergic conjunctivitis. Ophthalmology. 2003;110:487-492
9. Tomassini M, Magrini L, Bonini S, Lambiase A, Bonini S. Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis. Ophthalmology. 1994;101:1808-1811
10. Leonardi A, Borghesan F, Faggian D, Depaoli M, Secchi AG, Plebani M. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. Am J Ophthalmol. 2000;129:151
11. Leonardi A, Brun P, Tavolato M, Abatangelo G, Plebani M, Secchi A. Growth factors and collagen distribution in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2000;41:4175-4181
12. Lambiase A, Bonini S, Micera A, et al. Increased plasma levels of substance P in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 1997;38:2161-2164
13. Fujishima H, Takeyama M, Takeuchi T, Saito I, Tsubota K. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Allergy. 1997;27:372-378
14. Pucci N, Novembre E, Lombardi E, et al. Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms. Clin Exp Allergy. 2003;33:325-330
15. Bonini S, Bonini S, Schiavone M, Centofanti M, Allansmith MR, Bucci MG. Conjunctival hyperresponsiveness to ocular histamine challenge in patients with vernal conjunctivitis. J Allergy Clin Immunol. 1992;89:103-107
16. Pucci N, Novembre E, Cianferoni A, et al. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol. 2002;89:298-303
17. Liotet S, Riera M, Nguyen H. Les cils. Physiologie, structure, pathologie. Arch Ophthalmol. 1977;37:697-708
18. Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56:813-824
19. Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000;21:363-392
20. Bläuer M, Vaalasti A, Pauli SL, Ylikomi T, Joensuu T, Tuohimaa P. Location of androgen receptor in human skin. J Invest Dermatol. 1991;97:264-268
21. Randall VA, Hibberts NA, Thornton MJ, et al. The hair follicle: a paradoxical androgen target organ. Horm Res. 2000;54:243-250
22. Harrison DA, Mullaney PB. Familial trichomegaly. Arch Ophthalmol. 1997;115:1602-1603
23. Sampson JR, Tolmie JL, Cant JS. Oliver McFarlane syndrome: a 25-year follow-up. Am J Med Genet. 1989;34:199-201
24. Kaplan MH, Sadick NS, Talmor M. Acquired trichomegaly of the eyelashes: a cutaneous marker of acquired immunodeficiency syndrome. J Am Acad Dermatol. 1991;25:801-804
25. Baccard M, Morel P. Excessive growth of eyelashes in patients with acquired immunodeficiency syndrome. Cutis. 1994;53:83-84
26. Straka BF, Whitaker DL, Morrison SH, Oleske JM, Grant-Kels JM. Cutaneous manifestations of AIDS in children. J Am Acad Dermatol. 1988;18(suppl):1089-1102
27. Klutman NE, Hinthorm DR. Excessive growth of eyelashes in a patient with AIDS being treated with zidovudine. N Engl J Med. 1991;324:1896
28. Sharma RC, Mahajan VK, Sharma NL, Sharma A. Trichomegaly of the eyelashes in dermatomyositis. Dermatology. 2002;205:305
29. Santiago M, Travassos AC, Rocha MC, Souza S. Hypertrichosis in systemic lupus erythematosus (SLE). Clin Rheumatol. 2000;19:245-246
30. Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol. 1997;124:544-547
31. Sugimoto M, Sugimoto M, Uji Y. Quantitative analysis of eyelash lengthening following topical latanoprost therapy. Can J Ophthalmol. 2002;37:342-345
32. Fagot D, Buquet-Fagot C, Mester J. Mitogenic signaling by prostaglandins in chemically transformed mouse fibroblasts: comparison with phorbol esters and insulin. Endocrinology. 1993;132:1729-1734
33. Dikici B, Bosnak M, Dagli A, Haspolat K. Interferon alpha and hypertrichosis of eyelashes. Pediatr Infect Dis J. 2002;21:448-449
34. Foon KA, Dougher G. Increased growth of eyelashes in a patient given leukocyte A interferon. N Engl J Med. 1984;311:1259
35. Berglund EF, Burton GV, Mills GM, Nichols GM. Hypertrichosis of the eyelashes associated with interferon-alpha therapy for chronic granulocytic leukemia. South Med J. 1990;83:363
36. Hernandez-Nunez A, Fernandez-Herrera J, Buceta LR, Garcia-Diez A. Trichomegaly following treatment with interferon alpha-2b. Lancet. 2002;359:1107
37. Weaver DT, Bartley GB. Cyclosporine-induced trichomegaly. Am J Ophthalmol. 1990;109:239
38. Paus R, Stenn KS, Link RE. The induction of anagen hair growth in telogen mouse skin by cyclosporin A administration. Lab Invest. 1989;60:365-369
39. Apaydin C, Gur B, Yakupoglu G, Raka O. Ocular and visual side effects of systemic cyclosporine. Ann Ophthalmol. 1992;24:465-469
40. Dueland S, Sauer T, Lund-Johansen F, Østenstad B, Tveit KM. Epidermal growth factor receptor inhibition induces trichomegaly. Acta Oncol. 2003;42:345-346
41. Mansour AM, Bitar FF, Traboulsi EI, et al. Ocular pathology in congenital heart disease. Eye. 2004 May 7. Advance Online Publication; doi:1038/sj.eye. 6701408
42. Rubin PAD. Disorders of the eyelashes and eyebrows. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia, PA: WB Saunders; 1994:1852
43. Ozeki M, Tabata Y. Promoted growth of murine hair follicles through controlled release of basic fibroblast growth factor. Tissue Eng. 2002;8:359-366
44. Peters EM, Botchkarev VA, Botchkareva NV, Tobin DJ, Paus R. Haircycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. J Invest Dermatol. 2001;116:236-245
45. Lee WS, Sohn IB. Substance P prolongs human hair growth in vitro. J Dermatol Sci. 2003;33:137-138